News

Chair of the ACR COVID-19 Vaccine Clinical Guidance Task Force, Jeffrey Curtis, discusses the newest vaccine recommendations amid the Omicron variant.

Despite this, alexithymia was significantly associated with impaired quality of life and increased stigmatization levels in young students with acne.

Intravenous tramadol, developed by Avenue Therapeutics, fails to attain FDA approval as treatment for acute pain in adults.

An Israel cohort analysis suggests a "hybrid" of natural and vaccine-induced immunity is associated with the rare likelihood of SARS-CoV-2 reinfection.

The new hospital featured 50% private rooms, as well as regular cleaning and other preventative measures for C difficile infections.

Data showed that the greatest improvement before and after acne care was achieved after medical treatment by a dermatologist.

Califf previously served as FDA commissioner under the Obama Administration after a 35-year career at Duke University.

Dr. Yeung and colleagues offer insights into treating transmasculine patients who develop acne after gender-affirming testosterone therapy

A pilot trial suggests telemedicine methods need to be tailored to reach adversely affected populations including Black patients on Medicare or Medicaid.

Thinner RNFL and GCL were associated with lower Full Scale IQ in childhood and at age 45 years, while thinner RNFL in middle age was associated with greater decline in processing speed.

Sharp candidly discusses the need for new solution ideas to strike while the iron is hot, during this rebuilding stage of the healthcare system.

Vibeke Strand explains that secukinumab improves psoriatic arthritis in patients regardless of their treatment history.

A Finnish national study suggests hard-to-reach adults may seek a flu shot if provided direct information on its benefits.

Progressive familial intrahepatic cholestasis is a genetic liver disease that doesn't only affect the children who are diagnosed, but also the caregivers responsible for them.

Post hoc data from GATHER1 show the complement inhibitor's 18-month benefit in regions including the central fovea.

Data show the 5-year cumulative incidence of glaucoma was 46% among children with bilateral aphakia and 25% with unilateral aphakia.

Some indicators of suboptimal response included discontinuation of anti-TNF therapy for patients with ulcerative colitis and IBD-related hospitalization for patients with Crohn’s disease.

Phase 3 of the FUTURE 5 trial further examined the efficacious effect that secukinumab had on patients with psoriatic arthritis.

Data show atherosclerotic burden was heterogeneous across LDL-C levels and risk is shown to be consistently associated with plaque burden.

Investigator Andrew T. Chan, MD, MPH, discusses his team's recent findings showing a positive link between primary care providers per capita and community vaccination rates.

Data show ≥60% of eligible faricimab patients with DME could extend treatment to every 4 months, while 95% of ranibizumab implants in wetAMD treatment maintained a six-month schedule.

A new study highlights the urgency to implement better access and distribution of naloxone to avert witnessed opioid overdose deaths.

Dr. Yan noted that increased public awareness among patients and health care providers was essential for earlier detection of melanoma.

Experts explain the societal, systemic, and clinical challenges that come with managing skin disease in people of color.

More than half of dermatology practices have separated in recent years, which has influenced how skin of color and other areas of dermatology study are taught across the United States.

The program has returned with a renewed focus for Black and skin of color-dominant residency programs in addition to those with limited access to mentorship resources.

Dr. Shankar speaks to how physician training and patient conversations can evolve in dermatology through progressive antiracism efforts.

Previous studies reported that skin and soft tissue infections were common among persons experiencing homelessness.

Dr. Lipner says that primary investigators and sub-investigators can advocate for the diversification of clinical trial participants.

People with skin of color are often presumed to suffer fewer negative effects from solar radiation, making the importance of photoprotection in this population understudied and underestimated.